Login to Your Account



Other News To Note


Friday, January 4, 2013
• Icon Bioscience Inc., of Sunnyvale, Calif., said melphalan intraocular injection, its investigational product for treating retinoblastoma, was granted orphan designation by the FDA.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription